%0 Journal Article
%T Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease
%A Ayah Y Almasri
%A Laith N AL-Eitan
%A Sahar O Al-Habahbeh
%J Archive of "Pharmacogenomics and Personalized Medicine".
%D 2019
%R 10.2147/PGPM.S189838
%X The purpose of this study was to investigate the influence of CYP/CYP450 2C9 (CYP2C9) promoter variable number tandem repeat (p-VNTR) polymorphism on susceptibility to cardiovascular disease and on warfarin sensitivity and responsiveness, in Jordanians with cardiovascular disease during initiation and stabilization phases of therapy
%K warfarin
%K CYP2C9 promoter variable tandem repeat
%K polymorphism
%K cardiovascular disorder
%K oral anticoagulant
%K INR
%K warfarin dosage
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432888/